{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:08:56Z","timestamp":1790827736892,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.hpb.2024.04.014","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T14:53:47Z","timestamp":1714488827000},"page":"1007-1021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Improved outcomes of liver resection for hepatitis C-related hepatocellular carcinoma after the introduction of direct-acting antiviral therapy"],"prefix":"10.1016","volume":"26","author":[{"given":"Chiara","family":"Rocha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0212-7182","authenticated-orcid":false,"given":"Joseph","family":"Di Norcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parissa","family":"Tabrizian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Di Renzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0899-0534","authenticated-orcid":false,"given":"Salvatore","family":"Amodeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Bekki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4291-1385","authenticated-orcid":false,"given":"Mohammed Z.","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo E.","family":"Facciuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"Florman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9113-886X","authenticated-orcid":false,"given":"Myron","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2024.04.014_bib1","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/SLA.0000000000000917","article-title":"Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma. A retrospective analysis of a single north American center","volume":"260","author":"Franssen","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2024.04.014_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10620-013-2947-8","article-title":"Primary surgical resection versus liver transplantation for transplant eligible hepatocellular carcinoma patients","volume":"59","author":"Wong","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.hpb.2024.04.014_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11894-018-0626-9","article-title":"Considerations when treating hepatitis C in a cirrhotic transplant candidate","volume":"20","author":"Daniel","year":"2018","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.hpb.2024.04.014_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4254\/wjh.v7.i1.70","article-title":"Surgical approach for hepatitis C virus-related hepatocellular carcinoma","volume":"7","author":"Shindoh","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.hpb.2024.04.014_bib5","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.3748\/wjg.v25.i29.3929","article-title":"Hepatocellular carcinoma in the post-hepatitis C virus era: should we change the paradigm?","volume":"25","author":"Meringer","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hpb.2024.04.014_bib6","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jhep.2017.07.025","article-title":"Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: a systematic review, meta-analysis, and meta-regression","volume":"67","author":"Waziry","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.hpb.2024.04.014_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/liv.13659","article-title":"The impact of treatment of hepatitis C with DAAs on the occurrence of HCC","volume":"38","author":"Roche","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.hpb.2024.04.014_bib8","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/ijc.30521","article-title":"Impact of sustained viral response postcurative therapy of hepatitis C-related hepatocellular carcinoma: a systematic review and meta-analysis","volume":"140","author":"Manthravadi","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.hpb.2024.04.014_bib9","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.3748\/wjg.v24.i24.2582","article-title":"Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: a few lights and many shadows","volume":"24","author":"Guarino","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hpb.2024.04.014_bib10","article-title":"Impact of direct-acting antiviral therapy for hepatitis C-related hepatocellular carcinoma","volume":"15","author":"Lin","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.hpb.2024.04.014_bib11","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.jhep.2016.07.005","article-title":"Hepatitis C infection: a multi-faceted systemic disease with clinical, patient reported and economic consequences","volume":"65","author":"Younossi","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.hpb.2024.04.014_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/biomedicines8060175","article-title":"Risk factors contributing to the occurrence and recurrence of hepatocellular carcinoma in hepatitis C virus patients treated with direct-acting antivirals","volume":"8","author":"Kishta","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.hpb.2024.04.014_bib13","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/hepr.13547","article-title":"Clinical outcomes of direct-acting antiviral treatments for hepatitis C after hepatocellular carcinoma are equivalent to interferon treatment","volume":"50","author":"Tahata","year":"2020","journal-title":"Hepatol Res"},{"key":"10.1016\/j.hpb.2024.04.014_bib14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2016.06.015","article-title":"Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals","volume":"65","author":"Conti","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.hpb.2024.04.014_bib15","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1053\/j.gastro.2018.07.015","article-title":"Incidence of hepatocellular carcinoma after direct antiviral therapy for HCV in patients with cirrhosis included in surveillance programs","volume":"155","author":"Nahon","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2024.04.014_bib16","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2019.07.040","article-title":"Direct-Acting antiviral therapy for Hepatitis C virus infection is associated with increased survival in patients with a history of hepatocellular carcinoma","volume":"157","author":"Singal","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2024.04.014_bib17","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1053\/j.gastro.2019.01.027","article-title":"Direct-Acting antiviral therapy not associated with recurrence of hepatocellular carcinoma in a multicenter North American cohort study","volume":"156","author":"Singal","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2024.04.014_bib18","doi-asserted-by":"crossref","first-page":"12473","DOI":"10.3748\/wjg.v20.i35.12473","article-title":"Resection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcome","volume":"20","author":"Chau","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hpb.2024.04.014_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12876-017-0606-9","article-title":"Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis","volume":"17","author":"Bang","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.hpb.2024.04.014_bib20","unstructured":"Lui FH, Moosvi Z, Patel A, Hussain S, Duong A, Duong J, et\u00a0al. \u201cDecreased risk of hepatocellular carcinoma recurrence with direct-acting antivirals compared with no treatment for hepatitis C: a meta-analysis.\u201d Ann Gastroenterol 202:293-298."},{"key":"10.1016\/j.hpb.2024.04.014_bib21","article-title":"HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance","volume":"7","author":"Pascut","year":"2020","journal-title":"Hepatol Oncol"},{"key":"10.1016\/j.hpb.2024.04.014_bib22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jhep.2020.03.031","article-title":"DAA therapy and long-term hepatic function in advanced\/decompensated cirrhosis: real-world experience from HCV-TARGET cohort","volume":"73","author":"Verna","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.hpb.2024.04.014_bib23","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ags3.12377","article-title":"Viral elimination is essential for improving surgical outcomes of hepatitis C virus-related hepatocellular carcinoma: multicenter retrospective analysis","volume":"4","author":"Nakajima","year":"2020","journal-title":"Ann Gastroenterol Surg"},{"key":"10.1016\/j.hpb.2024.04.014_bib24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12876-023-02833-0","article-title":"Clinical characteristics, prognosis, and surgical outcomes of patients with non-HBV and non-HCV related hepatocellular carcinoma: three-decade observational study","volume":"23","author":"Yasukawa","year":"2023","journal-title":"BMC Gastroenterol"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X24012826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X24012826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T01:37:12Z","timestamp":1754012232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X24012826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1365182X24012826"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2024.04.014","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved outcomes of liver resection for hepatitis C-related hepatocellular carcinoma after the introduction of direct-acting antiviral therapy","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2024.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}